WINDTREE THERAPEUTICS INC /DE/ Weighted Average Number of Shares Outstanding, Basic and Diluted
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 24.76 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-31
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 28.19M shares, a 66.50% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 26.70M shares, a 61.07% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 26.35M shares, a 74.61% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 17.70M shares, a 29.19% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 24.76M shares, a 58.17% increase from fiscal 2020.
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 15.65M shares, a 43.25% increase from fiscal 2019.
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 10.93M shares, a 143.22% increase from fiscal 2018.
- WINDTREE THERAPEUTICS INC /DE/ weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 4.49M shares, a 436962.26% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | 28.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 27.45M shares derived: average of 2 quarters · filed 2022-03-31 | 27.08M shares derived: average of 3 quarters · filed 2022-03-31 | 24.76M shares 10-K · filed 2022-03-31 | ||||
| 2021-09-30 | 26.70M shares 10-Q · filed 2021-11-10 | 26.53M shares derived: average of 2 quarters · filed 2021-11-10 | 23.62M shares 10-Q · filed 2021-11-10 | 21.92M shares derived: average of 4 quarters · filed 2022-03-31 | ||||
| 2021-06-30 | 26.35M shares 10-Q · filed 2021-08-05 | 22.05M shares 10-Q · filed 2021-08-05 | 20.33M shares derived: average of 3 quarters · filed 2022-03-31 | 19.39M shares derived: average of 4 quarters · filed 2022-03-31 | ||||
| 2021-03-31 | 17.70M shares 10-Q · filed 2021-05-13 | 17.31M shares derived: average of 2 quarters · filed 2022-03-31 | 17.07M shares derived: average of 3 quarters · filed 2022-03-31 | 16.57M shares derived: average of 4 quarters · filed 2022-03-31 | ||||
| 2020-12-31 | 16.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 16.76M shares derived: average of 2 quarters · filed 2022-03-31 | 16.20M shares derived: average of 3 quarters · filed 2022-03-31 | 15.65M shares 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | 16.58M shares 10-Q · filed 2021-11-10 | 15.84M shares derived: average of 2 quarters · filed 2021-11-10 | 15.23M shares 10-Q · filed 2021-11-10 | 19.99M shares derived: average of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | 15.09M shares 10-Q · filed 2021-08-05 | 14.39M shares 10-Q · filed 2021-08-05 | 21.13M shares derived: average of 3 quarters · filed 2021-08-05 | 18.53M shares derived: average of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | 13.70M shares 10-Q · filed 2021-05-13 | 24.15M shares derived: average of 2 quarters · filed 2021-05-13 | 19.67M shares derived: average of 3 quarters · filed 2021-05-13 | 17.44M shares derived: average of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | 34.60M shares 10-K · filed 2020-04-03 | 22.66M shares derived: average of 2 quarters · filed 2020-11-16 | 18.69M shares derived: average of 3 quarters · filed 2020-11-16 | 10.93M shares 10-K · filed 2021-03-29 | 32.78M shares 10-K · filed 2020-04-03 | |||
| 2019-09-30 | 10.73M shares 10-Q · filed 2020-11-16 | 32.19M shares 10-Q · filed 2019-11-14 | 10.73M shares derived: average of 2 quarters · filed 2020-11-16 | 10.72M shares 10-Q · filed 2020-11-16 | 32.17M shares 10-Q · filed 2019-11-14 | 9.84M shares derived: average of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | 10.73M shares 10-Q · filed 2020-08-14 | 32.19M shares 10-Q · filed 2019-08-14 | 10.72M shares 10-Q · filed 2020-08-14 | 32.17M shares 10-Q · filed 2019-08-14 | 9.54M shares derived: average of 3 quarters · filed 2020-08-14 | 8.10M shares derived: average of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | 10.71M shares 10-Q · filed 2020-05-13 | 32.14M shares 10-Q · filed 2019-05-20 | 8.95M shares derived: average of 2 quarters · filed 2020-05-13 | 7.22M shares derived: average of 3 quarters · filed 2020-05-13 | 6.36M shares derived: average of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | 7.19M shares 10-K · filed 2020-04-03 | 5.48M shares derived: average of 2 quarters · filed 2020-04-03 | 4.90M shares derived: average of 3 quarters · filed 2020-04-03 | 4.49M shares 10-K · filed 2020-04-03 | 4.49K shares 10-K/A · filed 2019-04-23 | |||
| 2018-09-30 | 3.77M shares 10-K · filed 2020-04-03 | 3.76M shares derived: average of 2 quarters · filed 2020-04-03 | 3.58M shares 10-Q · filed 2019-11-14 | 2.27M shares derived: average of 4 quarters · filed 2020-04-03 | ||||
| 2018-06-30 | 3.75M shares 10-K · filed 2020-04-03 | 3.49M shares 10-Q · filed 2019-08-14 | 1.76M shares derived: average of 3 quarters · filed 2020-04-03 | 1.51M shares derived: average of 4 quarters · filed 2020-04-03 | ||||
| 2018-03-31 | 3.23M shares 10-K · filed 2020-04-03 | 771.06K shares derived: average of 2 quarters · filed 2020-04-03 | 757.04K shares derived: average of 3 quarters · filed 2020-04-03 | 694.53K shares derived: average of 4 quarters · filed 2020-04-03 | ||||
| 2017-12-31 | -1.68M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-23 | -477.94K shares derived: average of 2 quarters · filed 2019-04-23 | -149.63K shares derived: average of 3 quarters · filed 2019-04-23 | 1.03K shares 10-K/A · filed 2019-04-23 | 1.03M shares 10-K · filed 2018-04-17 | |||
| 2017-09-30 | 729.00K shares 10-Q · filed 2018-11-14 | 10.65M shares 10-Q · filed 2017-11-14 | 618.00K shares derived: average of 2 quarters · filed 2018-11-14 | 563.00K shares 10-Q · filed 2018-11-14 | 9.77M shares 10-Q · filed 2017-11-14 | 528.00K shares derived: average of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | 507.00K shares 10-Q · filed 2018-08-14 | 9.63M shares 10-Q · filed 2017-08-21 | 479.00K shares 10-Q · filed 2018-08-14 | 9.32M shares 10-Q · filed 2017-08-21 | 461.00K shares derived: average of 3 quarters · filed 2018-08-14 | 450.25K shares derived: average of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | 450.00K shares 10-Q · filed 2018-05-21 | 9.00K shares 10-Q · filed 2017-05-15 | 438.00K shares derived: average of 2 quarters · filed 2018-05-21 | 431.33K shares derived: average of 3 quarters · filed 2018-05-21 | 426.50K shares derived: average of 4 quarters · filed 2018-05-21 | |||
| 2016-12-31 | 426.00K shares 10-K · filed 2018-04-17 | 422.00K shares derived: average of 2 quarters · filed 2018-04-17 | 418.67K shares derived: average of 3 quarters · filed 2018-04-17 | 416.00K shares 10-K · filed 2018-04-17 | 8.33M shares 10-K · filed 2017-03-31 | |||
| 2016-09-30 | 418.00K shares 10-K · filed 2018-04-17 | 8.36M shares 10-Q · filed 2016-11-14 | 415.00K shares derived: average of 2 quarters · filed 2018-04-17 | 8.26M shares 10-Q · filed 2017-11-14 | 2.33M shares derived: average of 4 quarters · filed 2018-04-17 | |||
| 2016-06-30 | 412.00K shares 10-K · filed 2018-04-17 | 8.24K shares 10-Q · filed 2016-08-10 | 8.21M shares 10-Q · filed 2017-08-21 | 8.21K shares 10-Q · filed 2016-08-10 | 2.96M shares derived: average of 3 quarters · filed 2018-04-17 | 4.11M shares derived: average of 4 quarters · filed 2018-04-17 | ||
| 2016-03-31 | 410.00K shares 10-K · filed 2018-04-17 | 8.19M shares 10-Q · filed 2016-05-12 | 4.24M shares derived: average of 2 quarters · filed 2018-04-17 | 5.34M shares derived: average of 3 quarters · filed 2018-04-17 | 4.01M shares derived: average of 4 quarters · filed 2018-04-17 | |||
| 2015-12-31 | 8.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | 7.81M shares derived: average of 2 quarters · filed 2017-03-31 | 5.21M shares derived: average of 3 quarters · filed 2017-03-31 | 6.97M shares 10-K · filed 2017-03-31 | ||||
| 2015-09-30 | 7.55M shares 10-Q · filed 2016-11-14 | 3.78M shares derived: average of 2 quarters · filed 2016-11-14 | 6.60M shares 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | 6.13K shares 10-Q · filed 2016-08-10 | 6.12K shares 10-Q · filed 2016-08-10 | ||||||
| 2015-03-31 | 6.11M shares 10-Q · filed 2016-05-12 | 85.59M shares 10-Q · filed 2015-05-11 | ||||||
| 2014-03-31 | 84.73M shares 10-Q · filed 2015-05-11 | |||||||
| 2013-03-31 | 43.66M shares 10-Q · filed 2014-05-12 | 43.59M shares derived: average of 2 quarters · filed 2014-05-12 | 43.54M shares derived: average of 3 quarters · filed 2014-05-12 | 43.50M shares derived: average of 4 quarters · filed 2014-05-12 | ||||
| 2012-12-31 | 43.52M shares 10-K · filed 2014-03-17 | 43.52K shares 10-K · filed 2013-03-15 | 43.48M shares derived: average of 2 quarters · filed 2014-03-17 | 43.44M shares derived: average of 3 quarters · filed 2014-03-17 | 39.40M shares 10-K · filed 2014-03-17 | 39.40K shares 10-K · filed 2013-03-15 | ||
| 2012-09-30 | 43.44M shares 10-K · filed 2014-03-17 | 43.41M shares derived: average of 2 quarters · filed 2014-03-17 | 38.06M shares 10-Q · filed 2012-11-14 | 28.50M shares derived: average of 4 quarters · filed 2014-03-17 | ||||
| 2012-06-30 | 43.37M shares 10-K · filed 2014-03-17 | 35.33M shares 10-Q · filed 2012-08-14 | 23.52M shares derived: average of 3 quarters · filed 2014-03-17 | 17.64M shares derived: average of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | 27.16M shares 10-K · filed 2014-03-17 | 27.16K shares 10-K · filed 2013-03-15 | 13.59M shares derived: average of 2 quarters · filed 2014-03-17 | 9.07M shares derived: average of 3 quarters · filed 2014-03-17 | 6.81M shares derived: average of 4 quarters · filed 2014-03-17 | |||
| 2011-12-31 | 24.31K shares 10-K · filed 2013-03-15 | 24.21K shares derived: average of 2 quarters · filed 2013-03-15 | 24.15K shares derived: average of 3 quarters · filed 2013-03-15 | 22.66K shares 10-K · filed 2013-03-15 | ||||
| 2011-09-30 | 24.11K shares 10-K · filed 2013-03-15 | 24.11M shares 10-Q · filed 2012-11-14 | 24.07K shares derived: average of 2 quarters · filed 2013-03-15 | 22.10M shares 10-Q · filed 2012-11-14 | ||||
| 2011-06-30 | 24.03K shares 10-K · filed 2013-03-15 | 24.03M shares 10-Q · filed 2012-08-14 | 21.09M shares 10-Q · filed 2012-08-14 | |||||
| 2011-03-31 | 18.11K shares 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |